Immuno-oncology research collaboration with TCR2 Therapeutics
03-Jan-2017 -
University Hospital of Ludwig-Maximilians-University (LMU) Munich, Germany announced today a multi-year research collaboration with TCR2 Therapeutics Inc., an immuno-oncology company in Cambridge, Massachusetts, USA. Founder of TCR2 is Patrick Baeuerle, PhD, an internationally renowned tumor ...
collaborations
immuno-oncology
immunotherapies
+3